Rescue therapy for acute migraine, part 2: Neuroleptics, antihistamines, and others

Headache

Volumn 52, Issue 2, 2012, Pages 292-306

  Kelley, Nancy E ^a   Tepper, Deborah E ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

DHE; emergency; magnesium; migraine; treatment; triptan

Indexed keywords

BUPIVACAINE; CHLORPROMAZINE; DIHYDROERGOTAMINE; DIPHENHYDRAMINE; DROPERIDOL; GRANISETRON; HALOPERIDOL; HYDROXYZINE; IBUPROFEN; KETOROLAC; LEVOMEPROMAZINE; LIDOCAINE; MAGNESIUM; METOCLOPRAMIDE; NALBUPHINE; NITROUS OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OCTREOTIDE; OLANZAPINE; PETHIDINE; POTASSIUM; PROCHLORPERAZINE; PROMETHAZINE; PROPOFOL; SUMATRIPTAN; TRIPTAN DERIVATIVE; VALPROIC ACID;

ACUTE DISEASE; AKATHISIA; ANALGESIA; ANXIETY DISORDER; DIZZINESS; DROWSINESS; DRUG EFFICACY; DYSPEPSIA; DYSPHORIA; DYSTONIA; ELECTROCARDIOGRAM; FLUSHING; GASTROINTESTINAL SYMPTOM; HUMAN; INJECTION SITE BURNING; INJECTION SITE PAIN; INVOLUNTARY MOVEMENT; LETHARGY; MAGNESIUM BLOOD LEVEL; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MYALGIA; NAUSEA; ORTHOSTATIC HYPOTENSION; POTASSIUM BLOOD LEVEL; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; RECURRENT DISEASE; RESTLESSNESS; REVIEW; SEDATION; SIDE EFFECT; SLURRED SPEECH; SOMNOLENCE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TASTE DISORDER; THORAX PAIN; VISUAL ANALOG SCALE; WEAKNESS;

ANTIPSYCHOTIC AGENTS; HISTAMINE ANTAGONISTS; HUMANS; MEDLINE; MIGRAINE DISORDERS;

EID: 84856866330     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.02070.x     Document Type: Review

References (55)

1. Bigal ME, Bordini CA, Speciali JG,. Intravenous chlorpromazine in the emergency department treatment of migraine: A randomized controlled trial. J Emerg Med. 2002; 23: 141-148.
2. Evans RW, Young WB,. Droperidol and other neuroleptics/antiemetics for the management of migraine. Headache. 2003; 43: 811-813. (Pubitemid 36993025)
3. Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK,. Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department. Ann Emerg Med. 1994; 24: 237-241. (Pubitemid 24242237)
4. Jones J, Sklar D, Dougherty J, White W,. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989; 261: 1174-1176. (Pubitemid 19062453)
5. Coppola M, Yealy DM, Leibold RA,. Randomized, placebo-controlled evaluation of prochlorperazine vs metoclopramide for emergency department treatment of migraine headache. Ann Emerg Med. 1995; 26: 541-546.
6. Jones J, Pack S, Chun E,. Intramuscular prochlorperazine vs metoclopramide as single-agent therapy for the treatment of acute migraine headache. Am J Emerg Med. 1996; 14: 262-265. (Pubitemid 26152101)
7. Seim MB, March JA, Dunn KA,. Intravenous ketorolac vs intravenous prochlorperazine for the treatment of migraine headaches. Acad Emerg Med. 1998; 5: 573-576. (Pubitemid 28283652)
8. Ginder S, Oatman B, Pollack M,. A prospective study of I.V. magnesium and I.V. prochlorperazine in the treatment of headaches. J Emerg Med. 2000; 18: 311-315. (Pubitemid 30154068)
9. Tanen DA, Miller S, French T, Riffenburgh RH,. Intravenous sodium valproate vs prochlorperazine for the emergency department treatment of acute migraine headaches: A prospective, randomized, double-blind trial. Ann Emerg Med. 2003; 41: 847-853. (Pubitemid 36617539)
10. Miller MA, Levsky ME, Enslow W, Rosin A,. Randomized evaluation of octreotide vs prochlorperazine for ED treatment of migraine headache. Am J Emerg Med. 2007; 27: 160-164.
11. Callan JE, Kostic MA, Bachrach EA, Rieg TS,. Prochlorperazine vs promethazine for headache treatment in the emergency department: A randomized controlled trial. J Emerg Med. 2008; 35: 247-253.
12. Saadah H,. Abortive headache therapy in the office with intravenous dihydroergotamine plus prochlorperazine. Headache. 1992; 32: 143-146.
13. Friedman BW, Esses D, Solorzano C, et al,. A randomized controlled trial of prochlorperazine vs metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008; 52: 399-406.
14. Kostic MA, Gutierrez FJ, Rieg TS, Moore TS, Gendron RT,. A prospective, randomized trial of intravenous prochlorperazine vs subcutaneous sumatriptan in acute migraine therapy in the emergency department. Ann Emerg Med. 2010; 56: 1-6.
15. Iserson KV,. Parenteral chlorpromazine treatment of migraine. Ann Emerg Med. 1983; 12: 756-758. (Pubitemid 14203716)
16. McEwen JI, O'Connor HM, Dinsdale HB,. Treatment of migraine with intramuscular chlorpromazine. Ann Emerg Med. 1987; 16: 758-763. (Pubitemid 17113590)
17. Lane PL, McLellan BA, Baggoley CJ,. Comparative efficacy of chlorpromazine and meperidine with dimenhydrinate in migraine headache. Ann Emerg Med. 1989; 18: 360-365. (Pubitemid 19103771)
18. Bell R, Montoya D, Shuaib A, Lee MA,. A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med. 1990; 19: 1079-1082. (Pubitemid 20365193)
19. Kelly AM, Ardagh M, Curry C, D'Antonio J, Zebic S,. Intravenous chlorpromazine vs intramuscular sumatriptan for acute migraine. J Accid Emerg Med. 1997; 14: 209-211.
20. Harden RN, Gracely RH, Carter T, Warner G,. The placebo effect in acute headache management: Ketorolac, meperidine, and saline in the emergency department. Headache. 1996; 36: 352-356. (Pubitemid 26234956)
21. Davis CP, Torrre PR, Williams C, et al,. Ketorolac vs meperidine-plus-promethazine treatment of migraine headache: Evaluations by patients. Am J Emerg Med. 1995; 13: 146-150.
22. Scherl ER, Wilson JF,. Comparison of dihydroergotamine with metoclopramide vs meperidine with promethazine in the treatment of acute migraine. Headache. 1995; 35: 256-259.
23. Stiell IG, Dufour DG, Moher D, Yen M, Beilby WJ, Smith NA,. Methotrimeprazine vs meperidine and dimenhydrinate in the treatment of severe migraine: A randomized, controlled trial. Ann Emerg Med. 1991; 20: 1201-1205.
24. Kao LW, Kirk MA, Evers SJ, Rosenfeld SH,. Droperidol, QT prolongation, and sudden death: What is the evidence? Ann Emerg Med. 2003; 41: 546-558.
25. Lischke V, Behne M, Doelken P, Schledt U, Probst S, Vetterman J,. Droperidil causes a dose-dependent prolongation of the QT interval. Anesth Analg. 1994; 79: 983-986. (Pubitemid 24324682)
26. Silberstein SD, Young WB, Mendizabal JE, Rothrock JF, Alam AS,. Acute migraine treatment with droperidol: A randomized, double-blind, placebo-controlled trial. Neurology. 2003; 60: 315-321. (Pubitemid 36152029)
27. Miner JR, Fish SJ, Smith SW, Biros MH,. Droperidol vs prochlorperazine for benign headaches in the emergency department. Acad Emerg Med. 2001; 8: 873-879. (Pubitemid 32843793)
28. Weaver CS, Jones JB, Chisholm CD, et al,. Droperidol vs prochlorperazine for the treatment of acute headache. J Emerg Med. 2004; 26: 145-150. (Pubitemid 38234804)
29. Richman PB, Allegra J, Eskin B, et al,. A randomized clinical trial to assess the efficacy of intramuscular droperidol for the treatment of acute migraine headache. Am J Emerg Med. 2002; 20: 39-42. (Pubitemid 34052515)
30. Hill CH, Miner JR, Martel ML,. Olanzapine vs droperidol for the treatment of primary headache in the emergency department. Acad Emerg Med. 2008; 15: 806-811.
31. Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S,. Haloperidol in the acute treatment of migraine: A randomized, double-blind, placebo-controlled study. Headache. 2006; 46: 781-787.
32. Desmond PV, Watson KJ,. Metoclopramide-a review. Med J Aust. 1986; 144: 366-369.
33. Tek DS, McClellan DS, Olshakar JS, Allen CL, Arthur DC,. A prospective, double-blind study of metoclopramide hydrochloride for the control of migraine in the emergency department. Ann Emerg Med. 1990; 19: 1083-1087. (Pubitemid 20365194)
34. Ellis GL, Delaney J, DeHart DA, Owens A,. The efficacy of metoclopramide in the treatment of migraine headache. Ann Emerg Med. 1993; 22: 191-195. (Pubitemid 23058897)
35. Cete Y, Dora B, Ertan C, Ozdemir C, Oktay C,. A randomized perspective placebo-controlled study of intravenous magnesium sulfate vs metoclopramide in the management of acute migraine attacks in the Emergency Department. Cephalalgia. 2004; 25: 199-204. (Pubitemid 40321712)
36. Tfelt-Hansen P, Olesen J, Aebelholt-Krabbe A, Melgaard B, Veilis B,. A double blind study of metoclopramide in the treatment of migraine attacks. J Neurol Neurosurg Psychiatry. 1980; 43: 369-371. (Pubitemid 10083021)
37. Friedman BW, Corbo J, Lipton RB, et al,. A trial of metoclopramide vs sumatriptan for the emergency department treatment of migraines. Neurology. 2005; 64: 463-468. (Pubitemid 40189864)
38. Haugh MJ, Lavender L, Jensen A, Giuliano R,. An office-based double-blind comparison of dihydroergotamine vs dihydroergotamine/metoclopramide in the treatment of acute migraine. Headache. 1992; 32: 251.
39. Klapper JA, Stanton JS,. Ketorolac vs DHE and metoclopramide in the treatment of migraine headaches. Headache. 1991; 31: 523-524.
40. Edwards KR, Norton J, Behnke M,. Comparison of intravenous valproate vs intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001; 41: 976-980. (Pubitemid 34008133)
41. Belgrade MJ, Ling LJ, Schleevogt MB, Ettinger MG, Ruiz E,. Comparison of single-dose meperidine, butorphanol, and dihydroergotamine in the treatment of vascular headache. Neurology. 1989; 39: 590-592. (Pubitemid 19105782)
42. Klapper JA, Stanton JS,. Current emergency treatment of severe migraine headaches. Headache. 1993; 33: 560-562. (Pubitemid 23346606)
43. Friedman BW, Mulvey L, Esses D, et al,. Metoclopramide for acute migraine: A dose-finding randomized clinical trial. Ann Emerg Med. 2011; 57: 475-482.
44. Cicek M, Karcioglu O, Parlak I, et al,. Prospective, randomised, double blind, controlled comparison of metoclopramide and pethidine in the emergency treatment of acute primary vascular and tension type headache episodes. Emerg Med J. 2004; 21: 323-326. (Pubitemid 38590616)
45. Friedman BW, Hochberg M, Esses D, et al,. A clinical trial of trimethobenzamide/diphenhydramine vs sumatriptan for acute migraines. Headache. 2006; 46: 934-941. (Pubitemid 43794745)
46. Tek D, Mellon M,. The effectiveness of nalbuphine and hydroxyzine for the emergency treatment of severe headache. Ann Emerg Med. 1987; 16: 308-313. (Pubitemid 17025749)
47. Duarte C, Dunaway F, Turner L, Aldag J, Frederick R,. Ketorolac vs meperidine and hydroxyzine in the treatment of acute migraine headache: A randomized, prospective, double-blind trial. Ann Emerg Med. 1992; 21: 1116-1121.
48. Giordano J, Rogers LV,. Peripherally administered serotonin 5-HT3 receptor antagonists reduce inflammatory pain in rats. Eur J Pharmacol. 1989; 170: 83-86. (Pubitemid 19263225)
49. Rowat BMT, Merrill CF, Davis A, South V,. A double-blind comparison of granisetron and placebo for the treatment of acute migraine in the emergency department. Cephalalgia. 1991; 11: 207-213.
50. Cutrer FM,. Pathophysiology of migraine. Semin Neurol. 2010; 30: 120-130.
51. Mathew NT, Kailasam J, Meadors L, Chernyschev O, Gentry P,. Intravenous valproate sodium (Depacon) aborts migraine rapidly: A preliminary report. Headache. 2000; 40: 720-723.
52. Triner WR, Bartfield JM, Birdwell M, Raccio-Robak N,. Nitrous oxide for the treatment of acute migraine headache. Am J Emerg Med. 1999; 17: 252-254. (Pubitemid 29218262)
53. Krusz JC, Scott V, Belanger J,. Intravenous propofol: Unique effectiveness in treating intractable migraine. Headache. 2000; 40: 224-230. (Pubitemid 30169887)
54. Mellick LB, McIlrath ST, Mellick GA,. Treatment of headaches in the ED with lower cervical intramuscular bupivacaine injections: A 1-year retrospective review of 417 patients. Headache. 2006; 46: 1441-1449. (Pubitemid 44556435)
55. 3 receptor antagonists and migraine therapy. Neurology. 1991; 238: S53-S56.